Asthmatic Patients

azithromycin

University Hospital of Leuven

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.

Dominque Bullens

prof. dr.

Universitaire Ziekenhuizen Leuven

Patients will be randomized to receive either the active arm (3/4) or a SABA as rescue medication (1/4). The patient will be asked to take Qvar 100 (2puffs) in the morning and in the evening.
Daily dose (400 microgram).

Patients are allowed to use their SABA as rescue medication only. During the last 4 weeks, the patients will receive 400 microgram of Qvar.

Asthma

400 microgram of beclomethasone will be given to the patients in arm 1. During the last 4 weeks, the patients will receive additional 400 microgram of Qvar.

Beclomethasone

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2

We will evaluate steroid-responsiveness both by objective measurements (lung function parameters) and asthma scores

Chronic Hepatitis C

Chronic Hepatitis B

4-Methylumbelliferone (Heparvit®)

University Health Center Downtown "Brady/Green", 527 North Leona,

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)

galium mexicanum/נוגד דלקת

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע